Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 12,535 | 14,885 | 10,813 | 12,512 | 11,064 |
| Cost of Goods | 6,352 | 6,243 | 4,362 | 4,720 | 4,375 |
| Gross Profit | 6,183 | 8,642 | 6,451 | 7,792 | 6,689 |
| Operating Expenses | 20,091 | 20,943 | 18,440 | 21,100 | 19,772 |
| Operating Income | -13,556 | -12,058 | -11,627 | -12,588 | -12,708 |
| Interest Expense | 507 | 475 | 476 | 308 | 277 |
| Other Income | 147 | -89 | 59 | -16 | 62 |
| Pre-tax Income | -13,916 | -12,622 | -12,044 | -12,912 | -12,923 |
| Income Tax | 1 | 56 | 14 | -5 | 35 |
| Net Income Continuous | -13,917 | -12,678 | -12,058 | -12,907 | -12,958 |
| Net Income | $-13,917 | $-12,678 | $-12,058 | $-12,907 | $-12,958 |
| EPS Basic Total Ops | -0.30 | -0.28 | -0.27 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.30 | -0.27 | -0.27 | -0.30 | -0.30 |
| EPS Diluted Total Ops | -0.30 | -0.28 | -0.27 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.30 | -0.27 | -0.27 | -0.30 | -0.30 |
| EBITDA(a) | $-12,169 | $-10,742 | $-10,545 | $-11,601 | $-11,700 |